CEO David Endicott will present at the 2026 J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 8:15 a.m. PST.

Alcon Inc.'s acquisition of LENSAR, Inc. remains pending, with an FTC antitrust review likely delaying the closing. Learn ...

A fourth delay hits Staar Surgical’s shareholder vote on Alcon's $1.6B takeover as Broadwood Partners calls the deal flawed ...

STAAR Surgical Company (NASDAQ: STAA), the manufacturer of the Implantable Collamer® Lens (ICL) today announced that Alcon (SIX/NYSE: ALC) has exercised its right under the Alcon merger agreement to ...

GENEVA, SWITZERLAND – Many people would say that the first quarter of 2025 was pretty unpredictable for the business community. So, it shouldn’t be too much of a surprise when a company misses Wall ...

Alcon has experienced robust Q1 growth, driven by double-digit growth in vision care, particularly in the contact lens market. The company's strong revenue growth is attributed to successful product ...

Adds STAAR Surgical comment. STAAR Surgical (STAA) dropped 5% after proxy adviser Glass Lewis recommended holders reject the revised $30.75 a share offer from Alcon (ALC). “We do not believe there ...

Geneva, Switzerland-based Alcon and Orlando, FL-based Lensar have entered a merger agreement through which Alcon intends to acquire Lensar. The acquisition includes the Ally robotic cataract laser ...

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and STAAR Surgical Company (NASDAQ: STAA), the manufacturer of the Implantable Collamer® Lens (ICL), ...

Six years after being spun out from Novartis and becoming a public company, eye care specialist Alcon has gained its first FDA approval for a prescription drug, scoring a nod for dry eye disease (DED) ...

According to financial terms announced Monday night, Geneva, Switzerland-based Alcon will pay $15.25 for each share of Aerie, a 37% premium to the stock’s closing price on Monday. Aerie went public in ...

The series Point Break is set 35 years after the events of the original film and comes from David Kalstein and Alcon Entertainment.